These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1279788)

  • 1. [Cardiac interactions between ketanserin and the calcium antagonist nifedipine].
    Alberio L; Beretta-Piccoli C; Tanzi F; Koch P; Zehender M
    Schweiz Med Wochenschr; 1992 Nov; 122(45):1723-7. PubMed ID: 1279788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketanserin versus nifedipine in the treatment of essential hypertension in patients over 50 years old: an international multicenter study.
    Hannedouche T; Fillastre JP; Mimran A; de Tréglodé D; Schardt F; Rosenthal T; Grossman E; Rocco S
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S107-12. PubMed ID: 2446056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin. Multicenter Ketanserin Research Group.
    Zehender M; Meinertz T; Hohnloser S; Geibel A; Hartung J; Seiler KU; Just H
    Clin Physiol Biochem; 1990; 8 Suppl 3():90-100. PubMed ID: 2132179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.
    Janssens M; Symoens J
    J Hypertens Suppl; 1986 Dec; 4(6):S115-8. PubMed ID: 3302148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive efficacy of the combination of ketanserin + thiazide in hypertensives older than 50 years.
    Ferrara LA; Fasano ML; Soro S; Pasanisi F; Mancini M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S124-6. PubMed ID: 2446060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood pressure lowering action and tolerance of ketanserin in mono- or combination therapy].
    Beretta-Piccoli C; Amstein R; Bühler FR; Bertel O; Brunner HR; Follath F; Reutter F; Vallotton MB
    Schweiz Med Wochenschr; 1989 Mar; 119(12):399-406. PubMed ID: 2711155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss Ketanserin Study.
    Beretta-Piccoli C; Amstein R; Bertel O; Brunner HR; Bühler FR; Follath F; Solèr M; Vallotton M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S119-23. PubMed ID: 2446058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual and intravenous ketanserin versus sublingual nifedipine in the treatment of severe hypertension: a randomized study.
    Sechi LA; Tedde R; Cassisa L; Pala A; Orecchioni C; Uneddu F; Melis A
    Clin Ther; 1989; 11(6):834-40. PubMed ID: 2692825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of the efficacy and tolerance of delayed-action nifedipine as the monotherapy or in combination with metoprolol in patients with arterial hypertension].
    Isaĭkina OIu; Gorbunov VM; Andreeva GF; Dmitrieva NA; Martsevich SIu
    Ter Arkh; 2003; 75(12):39-43. PubMed ID: 14959468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antihypertensive effects of ketanserin and a ketanserin-hydrochlorothiazide combination administered once daily.
    Leary WP; Reyes AJ; van der Byl K; Maharaj B
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S127-34. PubMed ID: 2446061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
    Gambini G; Gradoli C; Proietti MG; Pinchi G; Fioroni E; Valori C
    Clin Ter; 1989 Jul; 130(2):101-7. PubMed ID: 2529082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of acute and chronic effects of ketanserin in the treatment of hypertension and hypothesis on a new mechanism of action].
    Sechi LA
    Ann Ital Med Int; 1990; 5(4 Pt 2):433-50. PubMed ID: 2102130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure during a combination of ketanserin and hydrochlorothiazide.
    Ferrara LA; Fasano ML; Soro S; Farinaro E; Celentano E; Mancini M
    Int J Clin Pharmacol Res; 1987; 7(6):463-8. PubMed ID: 3440636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of a calcium antagonist (nifedipine) in hypertensive and normotensive subjects].
    MacCarthy GB; Sánchez Torres G; Barrera JG
    Arch Inst Cardiol Mex; 1988; 58(2):137-43. PubMed ID: 2969712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C; Copertari P; Landi E; San Martin C; Lopes M; Feruglio F; Alcocer L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ketanserin and slow-release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta-adrenoceptor blocker.
    Waller PC; Solomon SA; Ramsay LE
    Br J Clin Pharmacol; 1987 Nov; 24(5):591-7. PubMed ID: 2893636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antihypertensive effect of nitrendipine, nifedipine and acebutolol and their combination on resting and exercise blood pressure in hypertensive patients].
    Franz IW; Wiewel D
    Z Kardiol; 1985 Feb; 74(2):111-6. PubMed ID: 3158125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee.
    Nifedipine-Atenolol Study Review Committee
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):468-72. PubMed ID: 2894883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW; Wiewel D
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.